Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.
about
Possible role of membrane gamma-glutamyltransferase activity in the facilitation of transferrin-dependent and -independent iron uptake by cancer cellsIron entry in neurons and astrocytes: a link with synaptic activityβ-thalassemia intermedia: a clinical perspectivePhytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathologyβ-thalassemias: paradigmatic diseases for scientific discoveries and development of innovative therapiesBlood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemiaIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesOxygen toxicity, oxygen radicals, transition metals and diseaseIron overload in sickle cell disease.Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.Oxidative stress and labile plasmatic iron in anemic patients following blood therapy.Hepatocellular carcinoma and African iron overload.Nature of nontransferrin-bound iron.Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states.Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis.Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.Iron dosing in kidney disease: inconsistency of evidence and clinical practice.Iron, lipocalin, and kidney epithelia.Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration.Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron.Iron, lactoferrin and iron regulatory protein activity in the synovium; relative importance of iron loading and the inflammatory response.Reversal of hemochromatosis by apotransferrin in non-transfused and transfused Hbbth3/+ (heterozygous B1/B2 globin gene deletion) mice.The long history of iron in the Universe and in health and disease.Polymeric nanocarriers for the treatment of systemic iron overload.SLC39A14 Is Required for the Development of Hepatocellular Iron Overload in Murine Models of Hereditary HemochromatosisElectron-microscopic and radioiron studies of iron uptake in newborn rat myocardial cells in vitroCD1 Mouse Retina Is Shielded From Iron Overload Caused by a High Iron DietIron overload and chelation.Non transferrin bound iron: nature, manifestations and analytical approaches for estimationSecond international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions.Pathophysiology and Clinical Manifestations of the β-Thalassemias.New developments and controversies in iron metabolism and iron chelation therapy.Hepatobiliary Quiz Answers-17 (2016).Can iron chelators influence the progression of atherosclerosis?Iron overload in myelodysplastic syndromes.Iron metabolism in children: confounding factorsUse of Nramp2-transfected Chinese hamster ovary cells and reticulocytes from mk/mk mice to study iron transport mechanismsReduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemiaClinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assay.
P2860
Q24803268-F894C523-5DFE-4D06-B2A5-300CDFA553BEQ26825777-50AD5FFC-5C6F-4481-B19A-C49E61C71F7DQ26828512-777BCD07-F542-498E-A581-916E07DD0AE8Q26863390-8AB91C32-5789-4660-B604-1E0562673A3EQ28086960-0E3959DE-2438-4B76-B177-37F64D51E01DQ28368958-5DE73A87-309B-49B0-9F20-8F0D188E0BC9Q28388335-4F91D13A-73A0-4823-A0F0-769C50EF1B8DQ29615096-24137E5C-1963-406A-9505-A61B0DEF1F00Q33861129-77CDC3FE-E517-41A1-B39A-C3D03913B63CQ34083003-8BE85C83-E90F-468B-A9C4-73D83F8F23ECQ34232983-962CEE60-1523-4E35-9164-568F6C8BFDFDQ34408927-684BAA6C-9863-415B-90E2-63263ED9C15DQ34557036-E12BE425-AA94-4D0C-B0A1-668AEC65606EQ34559341-E4A8FFE6-A06E-48B0-8F45-A315E7834323Q34625175-D685B9BE-8A7A-4662-A191-DC1A9941A25CQ34761250-AACEB7B3-320A-4BD3-8C39-045ED1A5CD9EQ35022235-72112D8B-047E-44EE-9671-58289451AEE5Q35146299-17599EBA-80C0-4864-9351-06E75D5694BAQ35288031-1DA791BE-1890-4013-B6C8-71BF77042441Q35322005-A467FA1B-42F7-439D-B17E-DBF7AA09908DQ35547880-3CFD0A42-FF79-42E9-8F1B-EFB3B0FBFEECQ35571019-C331C6D4-3748-4306-B24E-5026B6024F8BQ35672646-92C11637-03D5-4EF4-B463-30FDF8BB5CF4Q35673632-7E029B22-C6CC-419A-8067-B36EABBEC9C1Q35836771-A2E3945D-344A-4890-BDAE-CD6C6B8C0149Q35863599-6B12DB24-A7DF-4AFE-8F10-35FF0DD3D938Q35962930-C357426B-8693-4846-B88C-D525442D7738Q36270045-34FC95C0-3C9A-47C0-9BD2-7960ECC846E0Q36336362-8F322F13-94FF-47FE-9C9F-175BEE22CF4BQ36420736-40F30EF4-6F88-4D41-A97E-7FFF5C55CD2DQ36518457-AB10306F-CA11-4AD8-AF95-CA6197407A21Q36526536-ED58B396-1151-4437-A9E9-CBCC928C9AF0Q36719376-C9301E1A-AF0B-4842-B4A4-A0C183782794Q36886795-607DB664-A35C-4C96-9F71-D940BB99F401Q37084727-16682F7F-4444-43FF-BC03-27486EAC19A4Q37093678-53F3463F-14A9-4B9F-9858-CEDAE0A42F5EQ37093770-AA4F90AE-06DC-4586-BF91-D2A88BDF772EQ37128047-28451A98-5A29-45B4-AB19-13521F1FC6ADQ37314834-76E6AE87-3D77-46C7-9BBD-6EEE227133F3Q37416334-66FD77ED-E7CC-463B-B46C-9BB5EA9B6425
P2860
Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Non-specific serum iron in tha ...... raction of potential toxicity.
@en
Non-specific serum iron in tha ...... raction of potential toxicity.
@nl
type
label
Non-specific serum iron in tha ...... raction of potential toxicity.
@en
Non-specific serum iron in tha ...... raction of potential toxicity.
@nl
prefLabel
Non-specific serum iron in tha ...... raction of potential toxicity.
@en
Non-specific serum iron in tha ...... raction of potential toxicity.
@nl
P2093
P2860
P1476
Non-specific serum iron in tha ...... raction of potential toxicity.
@en
P2093
Rachmilewitz EA
P2860
P304
P356
10.1111/J.1365-2141.1978.TB03662.X
P407
P577
1978-10-01T00:00:00Z